A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

Clinical trial NCT06602453 · TERMINATED

Trial details

NCT number: NCT06602453
Sponsor: Genentech, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury

Start date: 2025-01-17
Primary completion: 2026-03-03
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.